Kristy Shield‐Artin

1.4k total citations
5 papers, 114 citations indexed

About

Kristy Shield‐Artin is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kristy Shield‐Artin has authored 5 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Kristy Shield‐Artin's work include DNA Repair Mechanisms (2 papers), interferon and immune responses (1 paper) and Cell death mechanisms and regulation (1 paper). Kristy Shield‐Artin is often cited by papers focused on DNA Repair Mechanisms (2 papers), interferon and immune responses (1 paper) and Cell death mechanisms and regulation (1 paper). Kristy Shield‐Artin collaborates with scholars based in Australia, Germany and United States. Kristy Shield‐Artin's co-authors include Izhak Haviv, Stephen B. Fox, Nicola Waddell, Max Yan, Huiling Xu, Michael J. McKay, Michelle Tang, Zikou Liu, David Komander and Aleksandra Bankovacki and has published in prestigious journals such as The EMBO Journal, Breast Cancer Research and BMC Cancer.

In The Last Decade

Kristy Shield‐Artin

5 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristy Shield‐Artin Australia	5	97	29	28	26	14	5	114
Rongyi Shi China	7	108 1.1×	17 0.6×	21 0.8×	15 0.6×	20 1.4×	10	141
Christel M. Davis United States	7	152 1.6×	30 1.0×	26 0.9×	12 0.5×	11 0.8×	12	203
Mingjun Fan China	9	120 1.2×	91 3.1×	23 0.8×	22 0.8×	11 0.8×	12	183
Lisa Dwane United Kingdom	3	115 1.2×	28 1.0×	35 1.3×	9 0.3×	16 1.1×	5	132
Natasha Silke Australia	6	87 0.9×	21 0.7×	32 1.1×	35 1.3×	14 1.0×	9	127
Maria Giovanna Jodice Italy	4	120 1.2×	32 1.1×	57 2.0×	11 0.4×	5 0.4×	4	140
Simona Punzi Italy	7	132 1.4×	57 2.0×	59 2.1×	13 0.5×	7 0.5×	11	174
Jenna H. Newman United States	5	50 0.5×	18 0.6×	42 1.5×	35 1.3×	5 0.4×	11	97
Bohan Dong China	8	72 0.7×	27 0.9×	25 0.9×	39 1.5×	10 0.7×	12	128
Jin‐Gyu Cheong United States	5	47 0.5×	18 0.6×	20 0.7×	24 0.9×	13 0.9×	8	92

Countries citing papers authored by Kristy Shield‐Artin

Since Specialization

Citations

This map shows the geographic impact of Kristy Shield‐Artin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristy Shield‐Artin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristy Shield‐Artin more than expected).

Fields of papers citing papers by Kristy Shield‐Artin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristy Shield‐Artin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristy Shield‐Artin. The network helps show where Kristy Shield‐Artin may publish in the future.

Co-authorship network of co-authors of Kristy Shield‐Artin

This figure shows the co-authorship network connecting the top 25 collaborators of Kristy Shield‐Artin. A scholar is included among the top collaborators of Kristy Shield‐Artin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristy Shield‐Artin. Kristy Shield‐Artin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Xu, Haineng, Sarah B. Gitto, Gwo‐Yaw Ho, et al.. (2024). CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer. iScience. 27(7). 109978–109978. 4 indexed citations

2.

Liu, Zikou, Laura F. Dagley, Kristy Shield‐Artin, et al.. (2021). Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis. The EMBO Journal. 40(23). e103718–e103718. 49 indexed citations

3.

Yan, Max, Kristy Shield‐Artin, David J. Byrne, et al.. (2015). Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers. BMC Cancer. 15(1). 506–506. 12 indexed citations

4.

Yan, Max, Huiling Xu, Nicola Waddell, et al.. (2012). Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers. Breast Cancer Research. 14(2). R69–R69. 35 indexed citations

5.

Shield‐Artin, Kristy, et al.. (2012). Identification of ovarian cancer‐associated proteins in symptomatic women: A novel method for semi‐quantitative plasma proteomics. PROTEOMICS - CLINICAL APPLICATIONS. 6(3-4). 170–181. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact